News

A drug discovery made at the University of Helsinki’s Faculty of Veterinary Medicine will increase the safety of animal sedation and anaesthesia. Vatinoxan, the pharmacological molecule discovered in the study, reduced the adverse effects of other drugs on the cardiovascular system of canine patients.

Babies exposed in the womb to the majority of medications that target neurotransmitter systems, including typical targets of antidepressants and antipsychotic drugs, are not any more likely to develop autism than non-exposed babies, according to research conducted at The Seaver Autism Center for Research and Treatment at the Icahn School of Medicine at Mount Sinai.

Researchers have found that the removal of mesencephalic astrocyte–derived neurotrophic factor MANF specifically from β-cells in adult mice results in the loss of β-cells in diabetes.

Researchers have provided fundamental new insight into the mechanism of the medical drug dimethyl fumarate, which is the active component of important treatments for multiple sclerosis and psoriasis. The results contribute to the development of new strategies for drug discovery.

Two fundamental quantum techniques have been combined by a UNSW team in a integrated silicon chip for the first time, confirming the promise of using silicon for quantum computing.

Liquid biopsy approach provides a molecular-based tool for tumor characterization, and is the first to indicate clinical utility of ctDNA for longitudinal surveillance of diffuse midline glioma.

The use of a soft, sponge electrode - instead of a traditional rigid metal electrode - provides a more natural environment for cell development.

Researchers are always seeking more reliable and more efficient communications, for everything from televisions and cellphones to satellites and medical devices. However, some of the most exciting techniques are highly energy demanding. Now, researchers are using brain-inspired machine learning techniques to increase the energy efficiency of wireless receivers to make communications greener.

DNA-damaging agents, or "DDAs," make up the most widely used group of cancer drugs. Yet their therapeutic success has been curtailed by drug resistance. Now, biologists have discovered a new way of re-sensitizing drug-resistant human tumor cells to the potency of DDAs.

A systematic review of research has revealed that the toxic effects on the lung of drugs commonly taken to treat a range of common conditions is much more widespread than thought.